HE
HERB.US Yasheng Group
- Market cap
- USD 4.51M
- P/E
- 0.3x
- P/B
- -
- ROE
- 2.8%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2024.
Is HERB.US undervalued?
Graham numberThe Graham number of Yasheng Group cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Yasheng Group fundamental analysis
No fundamental analysis for Yasheng Group yet.
Yasheng Group stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Yasheng Group
Humanoid, Inc., through its subsidiaries, designs, develops, manufactures, and markets farming and sideline products; chemical materials and products; textiles; construction materials; and livestock and poultry products. It cultivates, processes, markets, and distributes various food and agro-byproducts; and manufactures and supplies nutrition and healthcare products. The company's products portfolio includes cotton and wool, sorghum, grains, barley, soybean, alfalfa, corn, …
Full company profileYasheng Group financial statements
Yasheng Group annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2012 | 2013 | 2014 | 2015 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 993M | 1.01B | 1.01B | 939M | 8.68M | 12.5M | 14.0M | 18.6M | 21.1M | 24.1M |
| Gross Profit | 133M | 143M | 144M | 119M | 1.22M | 3.24M | 4.01M | 5.59M | 7.04M | 8.08M |
| Operating Income | 127M | 137M | 138M | 113M | 778K | 2.74M | 3.46M | 4.91M | 6.26M | 7.20M |
| EBITDA | 138M | 151M | 153M | 127M | 1.29M | 3.02M | 3.76M | 5.21M | 7.42M | 7.66M |
| Net Income | 126M | 136M | 139M | 112M | 1.01M | 2.99M | 3.72M | 5.31M | 7.02M | 8.07M |
| EPS | 0.82 | 0.88 | 0.90 | 0.65 | 0.01 | 0.02 | 0.02 | 0.03 | 0.04 | 0.05 |
| Balance Sheet | ||||||||||
| Total Assets | 2.16B | 2.35B | 2.48B | 258M | 245M | 265M | 265M | 269M | 275M | 290M |
| Total Liabilities | 79.6M | 68.5M | 58.2M | 45.8M | 3.19M | 3.97M | 3.42M | 4.57M | 5.77M | 6.16M |
| Shareholders' Equity | 2.08B | 2.28B | 2.42B | 213M | 242M | 261M | 262M | 264M | 269M | 284M |
| Cash & Short-term Investments | 11.0M | 11.3M | 11.9M | 1.40M | 2.14M | 3.35M | 3.75M | 4.18M | 6.08M | 8.53M |
| Total Debt | 42.6M | 11.0M | 8.46M | 45.7M | 2.70M | 2.78M | 2.23M | 1.69M | 2.05M | 232K |
| Cash Flow | ||||||||||
| Operating Cash Flow | 34.1M | 51.1M | 116M | 321M | -605K | -553K | 2.44M | 2.40M | 3.77M | 5.49M |
| Capital Expenditure | 11.1M | 43.8M | 110M | 324M | 2.12M | 335K | 500K | 2.00M | 1.05M | 2.75M |
| Free Cash Flow | 23.0M | 7.31M | 6.05M | -3.31M | -2.72M | -888K | 1.94M | 398K | 2.72M | 2.74M |
| Ratios | ||||||||||
| ROE | 6.1% | 6.0% | 5.7% | 52.6% | 0.4% | 1.1% | 1.4% | 2.0% | 2.6% | 2.8% |
| ROA | 5.9% | 5.8% | 5.6% | 43.3% | 0.4% | 1.1% | 1.4% | 2.0% | 2.6% | 2.8% |
| Net Profit Margin | 12.7% | 13.5% | 13.7% | 11.9% | 11.7% | 23.8% | 26.5% | 28.6% | 33.2% | 33.4% |
| Debt to Equity | 0.02x | 0.00x | 0.00x | 0.21x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.00x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Yasheng Group dividends
Yasheng Group has not paid dividends in the last 10 fiscal years.
Last stock split: 11:10 on May 13, 2022.
Who owns Yasheng Group
- Insiders 0.00%
- Institutions 0.01%
- Public & others 99.99%
- Shares outstanding 157M
Yasheng Group company profile
- Company name
- Yasheng Group
- Ticker
- HERB.US
- Exchange
- USA Stocks
- Listed since
- May 6, 2004
- Sector
- Consumer Defensive
- Industry
- Food Products
- Employees
- 10,000
- Fiscal year end
- December
- Address
- 710 Lakeway Drive, Sunnyvale, CA, United States, 94085
- Phone
- 86 93 1885 7181
- Website
- yashenggroup.com
About Yasheng Group
Humanoid, Inc., through its subsidiaries, designs, develops, manufactures, and markets farming and sideline products; chemical materials and products; textiles; construction materials; and livestock and poultry products. It cultivates, processes, markets, and distributes various food and agro-byproducts; and manufactures and supplies nutrition and healthcare products. The company's products portfolio includes cotton and wool, sorghum, grains, barley, soybean, alfalfa, corn, and wheat; onions, beets, lupin, bell peppers, potato, peas, carrots, and brussels potato; fuji apple, wolf berry, water melons, apricots, hami melons, peaches, chinese pear, tomato, grapes, dates, yellow river melons, and medlar; hops, nursery crops, liquorices root, flaxseed, aloe plant, TCM herbs, and ginseng; oil seeds, black melon, sunflower, corn; and chicken, pigs, sheep, eggs, and cows. In addition, it produces drip irrigation equipment, fertilizers, and animal feeds; and engages in the acquisition and development of gold, silver, and other mineral properties. The company operates in the United States, the People's Republic of China, and the Philippines. Humanoid, Inc. also exports its products. The company was formerly known as YaSheng Group and changed its name to Humanoid, Inc. in April 2024. The company was founded in 1998 and is headquartered in Sunnyvale, California. Humanoid, Inc. is a subsidiary of Gansu Yasheng Salt Chemical Industrial Group, Ltd.
Yasheng Group management
5- Mr. Haiyun ZhuangCFO, Treasurer, Secretary & Director · born 1970
- Mr. Weihao CuiCEO, President & Director · born 1972
- Mr. Darong LiuCOO & Director · born 1966
- Mr. Robert CardinalSenior Financial Officer & Director · born 1952
- Mr. Chen Eric ChristopherSenior VP & Director · born 1959